COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

<p><strong>Aim.</strong> To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ), possibility of...

Full description

Bibliographic Details

Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Subjects:	метопролол тартрат метопролол сукцинат артериальная гипертония антигипертензивная терапия
Online Access:	http://www.rpcardio.ru/jour/article/view/367